0114 GMT - AMMB Holdings' canceling the sale of its life insurance unit to Great Eastern comes as no surprise, given the prolonged delay, Maybank IB analyst Desmond Ch'ng says in a note. He notes that there has been no progress on the deal since it was first proposed in October 2023. The impact on AMMB's capital is minimal, with its Common Equity Tier 1 ratio at a solid 15.3%, he reckons. While a sale may still be considered, there is no urgency, he adds. Ch'ng expects AMMB to see 11.7% earnings growth in FY 2025, supported by better net interest margins and lower credit costs. Maybank maintains a buy rating on AMMB and keeps the target price at MYR6.30. Shares are 0.2% higher at MYR5.65. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
February 03, 2025 20:14 ET (01:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。